Funding Opportunities

SCN is pleased to launch a new funding competition to support high-quality translational research and clinical trials in stem cell and regenerative medicine research. The competition opened August 8, 2017 and will run through to October 16, 2017. SCN anticipates awarding approximately $4 million through this peer-reviewed competition. The funding will support novel research that will ultimately realize both health and economic benefits for Canadians.

Click here to read the full statement.


CLINICAL TRIAL RESEARCH AGREEMENT PROGRAM

Value: $500, 000 for eleven months (April 1, 2018 to February 28, 2019)

Timelines:
Call for Proposals Open – August 8, 2017
Call for Proposals Closes – October 16, 2017, 11:59 PM, EDT.
Award Notifications – February, 2018

 

*All research funding is subject to completion and approval of the SCN-Government of Canada Contribution Agreement for 2018-19

Clinical Trial Research Agreements is to support projects that focus on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Eligible clinical trials must be at the Phase I or II stage, and have received both Research Ethics Board and CTA approval from Health Canada. It is expected that successful projects will show incremental benefit to the patient and provide an economic analysis of the potential cost of treatment compared to current best available standard of care.

View Guidelines
Download Application Form
Download Budget Template
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com


DISEASE TEAM RESEARCH AGREEMENT PROGRAM

Value: $200,000 for eleven months (April 1, 2018 to February 28, 2019)

Timelines:
Call for Proposals Open – August 8, 2017
Call for Proposals Closes – October 16, 2017, 11:59 PM, EDT.
Award Notifications – February, 2018

 

*All research funding is subject to completion and approval of the SCN-Government of Canada Contribution Agreement for 2018-19

Disease Team Research Agreements will support projects that are developing novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. This includes, cell-based, protein-based, small molecule based or other approaches. Proposals must clearly describe the translational bench to bedside path of the research and identify where the proposed research stands along the path.

View Guidelines
Download Application Form
Download Budget Template
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com


IMPACT RESEARCH AGREEMENT PROGRAM (IRAP)

Value: $100,000 for eleven months (April 1, 2018 to February 28, 2019)
Value Public Policy stream: $40,000 for eleven months (April 1, 2018 to February 28, 2019)

The Impact Research Agreement Program has four funding streams (Translational, Clinical Translation, Commercialization and Public Policy).

Timelines:
Call for Proposals Open – August 8, 2017
Call for Proposals Closes – October 16, 2017, 11:59 PM, EDT.
Award Notifications – February, 2018

*All research funding is subject to completion and approval of the SCN-Government of Canada Contribution Agreement for 2018-19

Download budget templates for all IRAP streams

 

Translational Impact Research Agreements support early stage translational projects that have the potential to develop novel therapeutic stem cell approaches to tissue repair and regeneration within a disease model. Proposals must clearly identify the translational “bench to bedside” path of the research and where the proposed research stands along the path. Projects that may be funded within this program can involve proof-of-principle experiments, development of new models, expression and epigenetic studies to understand behavior of stem and progenitor cells in disease relevant settings. Projects may also involve identification and characterization of compounds/drugs that target stem cell differentiation/proliferation with the aim to develop novel therapeutic approaches.

View Guidelines
Download Application Form
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com

Clinical Translation & Accelerator Impact Research Agreements support projects that develop novel cellular or therapeutic stem cell approaches to tissue repair and regeneration within specific disease models. In addition, projects that are nearing Health Canada clinical trial initiation will also be eligible for support. Proposals must clearly identify the translational “bench to bedside” path of the research and where the proposed research stands along the path. Projects that are principally focused on basic research activities are not encouraged.

View Guidelines
Download Application Form
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com

Commercialization Impact Research Agreements support projects that generate novel technologies and intellectual property that have commercial value in the stem cell research or therapeutics markets.

View Guidelines
Download Application Form
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com

Public Policy Impact Research Agreements support projects that address public policy issues relevant to stem cell research. Projects may also consist of a workshop or series on critical stem cell related issues, with the goal to bring together different stakeholder groups to stimulate discussion and generate briefing documents, white papers and/or policy recommendations. Examples of issues that may be addressed through the Public Policy stream include research ethics, derivation and use of human embryonic stem cells, animal models, patient rights, and use of new technologies. Applications in new or emerging areas are also welcome, for example: access and allocation issues; issues in the use of unproven cell therapies, and reimbursement issues.

Value: $40,000 for eleven months (April 1, 2018 to February 28, 2019)

View Guidelines
Download Application Form
Download Institutional and Investigator Signature Form

Applications must be emailed by October 16, 2017 at 11:59 PM, EDT to: info@stemcellnetwork.ca and/or scn.rcs2016@gmail.com